United States · pharmaceuticals

Cardeas Pharma

Cardeas Pharma specializes in early-phase development of inhaled antibiotics to treat respiratory infections.

ClosedFor profit

pharmaceuticalsSeattle, United States

Why reach out now

What the record says about Cardeas Pharma as a customer or partner.

Against its peers

Set against 302 pharmaceuticals companies in United States. The ring marks the typical peer.

Staff11-50The typical size for its peers
Founded20106 years before the typical peer (2016)

Across all 5.9M companies: larger than 33% of those with a size listed; older than 5% of those with a founding year.

About Cardeas Pharma

What it does

BiotechnologyHealth CareMedical

Funding, as listed

What the source datasets report. We have not watched these rounds ourselves.

$80M

raised in total, currency not stated across 3 rounds

Last raised Apr 2015, 11 years ago

Rounds
3
Latest round
Series b
Investors
62 leading

Key facts

Who started it and how it trades.

Founded by
Bruce Montgomery

Every detail we hold

Everything the source datasets list about Cardeas Pharma, field by field. Contact details are held but never shown.

The company7 fields

Name
Cardeas Pharma
Type
For profit
Status
Closed
Founded
2010
Founders
Bruce Montgomery
Industry
pharmaceuticals
Categories
Biotechnology, Health Care, Medical

Where3 fields

City
Seattle
Country
United States
Markets
Greater Seattle Area, West Coast, Western US

Size and reach1 field

Staff band
11-50
Show 9 more fieldsShow fewer fields

Funding, as listed7 fields

Total
80,000,000 (currency not stated)
Rounds
3
Latest round
Series b
Latest round date
Apr 2015
Investors
6
Lead investors
2
Listing status
private

About this record2 fields

Sources
Crunchbase
Last imported
Sept 2026

Companies like Cardeas Pharma

pharmaceuticals in United States.

Build a lead list

302 pharmaceuticals companies in United States, filtered by size, age and reach, ready to export with emails on Pro.

Open the list